Form 8-K - Current report:
SEC Accession No. 0001558370-22-018593
Filing Date
2022-12-13
Accepted
2022-12-13 16:05:41
Documents
13
Period of Report
2022-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20221207x8k.htm   iXBRL 8-K 38405
2 EX-10.1 tmb-20221207xex10d1.htm EX-10.1 61093
  Complete submission text file 0001558370-22-018593.txt   232528

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20221207.xsd EX-101.SCH 3059
4 EX-101.LAB tmb-20221207_lab.xml EX-101.LAB 16017
5 EX-101.PRE tmb-20221207_pre.xml EX-101.PRE 10424
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221207x8k_htm.xml XML 4852
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 221459742
SIC: 2834 Pharmaceutical Preparations